Get started
Author

Michael Minaai

Observed name: M Minaai
ORCID: 0000-0002-4397-1507
Observed ORCID: 0000-0002-4397-1507
OpenAlex ID: A5011606705
Mesothelioma: Scientific clues for prevention, diagnosis, and therapy
2019 · Michele Carbone, Prasad S. Adusumilli, et al. · CA A Cancer Journal for Clinicians · 455
PDF
HMGB1 as a therapeutic target in disease
2020 · Jiaming Xue, Joelle S. Suarez, et al. · Journal of Cellular Physiology · 296
A Subset of Mesotheliomas With Improved Survival Occurring in Carriers ofBAP1and Other Germline Mutations
2018 · Sandra Pastorino, Yoshie Yoshikawa, et al. · Journal of Clinical Oncology · 144
Medical and Surgical Care of Patients With Mesothelioma and Their Relatives Carrying Germline BAP1 Mutations
2022 · Michele Carbone, Harvey I. Pass, et al. · Journal of Thoracic Oncology · 97
PDF
Combined Genetic and Genealogic Studies Uncover a Large BAP1 Cancer Syndrome Kindred Tracing Back Nine Generations to a Common Ancestor from the 1700s
2015 · Michele Carbone, Erin G. Flores, et al. · PLoS Genetics · 89
PDF
Heterozygous germline BLM mutations increase susceptibility to asbestos and mesothelioma
2020 · Angela Bononi, Keisuke Goto, et al. · Proceedings of the National Academy of Sciences · 52
PDF
BAP1 forms a trimer with HMGB1 and HDAC1 that modulates gene × environment interaction with asbestos
2021 · Flavia Novelli, Angela Bononi, et al. · Proceedings of the National Academy of Sciences · 35
PDF
HMGB1 released by mesothelial cells drives the development of asbestos-induced mesothelioma
2023 · Joelle S. Suarez, Flavia Novelli, et al. · Proceedings of the National Academy of Sciences · 32
BAP1 is a novel regulator of HIF-1α
2023 · Angela Bononi, Qian Wang, et al. · Proceedings of the National Academy of Sciences · 31
Inhibition of the spindle assembly checkpoint kinase Mps-1 as a novel therapeutic strategy in malignant mesothelioma
2017 · A Szymiczek, M Carbone, et al. · Oncogene · 28
Clinical and Pathologic Phenotyping of Mesotheliomas Developing in Carriers of Germline BAP1 Mutations
2025 · Michele Carbone, Michael Minaai, et al. · Journal of Thoracic Oncology · 26
Preventive and therapeutic opportunities: targeting BAP1 and/or HMGB1 pathways to diminish the burden of mesothelioma
2023 · Michele Carbone, Michael Minaai, et al. · Journal of Translational Medicine · 20
PDF
Germline BARD1 variants predispose to mesothelioma by impairing DNA repair and calcium signaling
2024 · Flavia Novelli, Yoshie Yoshikawa, et al. · Proceedings of the National Academy of Sciences · 14
PDF
Advances in the Basic Sciences in Thoracic Oncology in the Last 20 Years and Their Translational Impact
2026 · Michele Carbone, Christopher Amos, et al. · Journal of Thoracic Oncology · 3
PDF
Genome-guided, field-deployable loop-mediated isothermal amplification (LAMP) assay for specific detection of Dickeya dadantii
2024 · Stefania Montesinos, Garima Tyagi, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 1
Corrigendum to ‘Advances in the Basic Sciences in Thoracic Oncology in the Last 20 Years and Their Translational Impact’ [Journal of Thoracic Oncology Volume 21 Issue 1 (2026) 41-76]
2026 · Michele Carbone, Christopher Amos, et al. · Journal of Thoracic Oncology
PDF
A Response to the Letter to the Editor: Refining Risk and Redefining Stage: Hidden Implications of BAP1-Mutant Mesothelioma Shiuan-Chih Chen, MD, PhD; Yuan-Ti Lee, MD, PhD
2025 · Michele Carbone, Michael Minaai, et al. · Journal of Thoracic Oncology
Biomolecular Pathways in Mesothelioma: What Is New Perspective on Biomolecular Research for Mesothelioma?
2021 · Giovanni Gaudino, Michael Minaai, et al. · Respiratory disease series
Genetic Predisposition to Mesothelioma: What Are the Biological Mechanisms and What Are the Clinical Characteristics of These Mesotheliomas?
2021 · Michele Carbone, Michael Minaai, et al. · Respiratory disease series
Works count: 19
Citation count: 1,316
H-index: 13
I10-index: 13
Year
Topic
Type